Li, Yuchen https://orcid.org/0000-0001-7091-3073
Lim, Chaemin
Dismuke, Taylor
Malawsky, Daniel S. https://orcid.org/0000-0003-4421-8688
Oasa, Sho https://orcid.org/0000-0003-3800-590X
Bruce, Zara C.
Offenhäuser, Carolin https://orcid.org/0000-0003-2518-1779
Baumgartner, Ulrich https://orcid.org/0000-0001-8170-0567
D’Souza, Rochelle C. J.
Edwards, Stacey L. https://orcid.org/0000-0001-7428-4139
French, Juliet D. https://orcid.org/0000-0002-9770-0198
Ock, Lucy S. H. https://orcid.org/0000-0002-1680-3954
Nair, Sneha
Sivakumaran, Haran https://orcid.org/0000-0002-4691-4989
Harris, Lachlan https://orcid.org/0000-0002-7820-0921
Tikunov, Andrey P.
Hwang, Duhyeong
Alicea Pauneto, Coral Del Mar
Maybury, Mellissa
Hassall, Timothy
Wainwright, Brandon
Kesari, Santosh https://orcid.org/0000-0003-3772-6000
Stein, Gregory https://orcid.org/0000-0002-3588-8834
Piper, Michael
Johns, Terrance G. https://orcid.org/0000-0002-8874-4543
Sokolsky-Papkov, Marina https://orcid.org/0000-0002-3462-9013
Terenius, Lars https://orcid.org/0000-0003-2880-9576
Vukojević, Vladana https://orcid.org/0000-0003-0873-5653
McSwain, Leon F.
Gershon, Timothy R. https://orcid.org/0000-0001-7034-6400
Day, Bryan W.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS088219, R01NS102627, R01NS106227)
Article History
Received: 17 May 2023
Accepted: 22 November 2024
First Online: 4 February 2025
Competing interests
: G.S. is the Chief Executive Officer, Chairman of the Board and has equity ownership at Curtana Pharmaceuticals. S.K. is a member of the Board and has equity ownership at Curtana Pharmaceuticals. The other co-authors have no competing interests to report.